Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
Total net revenue of $15.2 millionAdjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments$30.0 million cash balance at December...
Pregnancy
SCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium
Company highlights accelerating access and revenue growth for ARBLI™ and confirms REZENOPY™ launch timeline, addressing a combined US annual losartan...
Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center
OMER, Israel, Feb. 2, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a...
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
GoodRx to offer prescription savings of up to 30% for ARAKODA® (tafenoquine)Collaboration designed to lower patient out-of-pocket costs and expand the...
Kirkman(R) Unveils Revolutionary L Reuteri: a Brain-Protective Probiotic with Immune Benefits
Lake Oswego, Oregon--(Newsfile Corp. - February 2, 2026) - Functional Brands Inc. (NASDAQ: MEHA), parent company of Kirkman®, a trusted...
Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive November 2025 fire at Keswick...
Launching a Think Tank to Advance Maternal Vitality in Georgia
The Maternal Health Vitality Think Tank unites cross-sector leaders to transform care, strengthen workforce, and align resourcesATLANTA, Jan. 29, 2026...
Launching a Think Tank to Advance Maternal Vitality in Georgia
The Maternal Health Vitality Think Tank unites cross-sector leaders to transform care, strengthen workforce, and align resourcesATLANTA, Jan. 29, 2026...
Carrot Expands Industry-Leading Flexible Plan Design With New Cycle-Based Fertility Option
Customers can now tailor fertility benefits coverage with either dollar-maximum or cycle-based plan designs, while maintaining full price transparency and...
A Vision Realized: The Tamer Institute for Women’s Health
University of Miami Health System (UHealth) Announces a Transformational Gift from Tony and Sandra Tamer to Establish the Tamer Institute...
Who Does the Best Mommy Makeover in Florida?
The Best Mommy Makeover in Florida is by Dr. Sessa. SARASOTA, FL / ACCESS Newswire / January 27, 2026 /...
Waymark Signal Identifies High-Risk Pregnancies 55 Days Earlier Than Traditional Methods, Study Shows
New peer-reviewed research demonstrates breakthrough in early detection of adverse pregnancy outcomes for Medicaid patients, achieving 89% accuracy while eliminating...
Babylist Launches Birth with Babylist, a New Podcast Reimagining How Expecting Parents Prepare for Birth
EMERYVILLE, Calif., Jan. 22, 2026 /PRNewswire/ -- Babylist, the leading platform for growing families, today announced the launch of Birth...
60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria Prevention
Partnership adds a travel-focused consumer telehealth platform to the ARAKODA® marketing strategy, offering a new convenience to people planning travel...
WIN Expanded Preconception Program: AI-Driven, Data-Informed, and Clinical-Led Personalized Care for Every Stage of the Journey
Companies integrating the program achieve improved outcomes, reduced high-cost claims, and greater employee satisfaction GREENWICH, Conn., Jan. 21, 2026 /PRNewswire/...
ProgenyHealth Releases 2026 Maternal & Infant Health Trends Report
Report identifies 5 emerging trends within maternal and infant health and what they reveal about the state of the industry now...
Aytu BioPharma Recaps Investor Day Held on January 20, 2026
DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical...
Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA
EXXUA addresses frequent causes of treatment discontinuation with first-line SSRIs and SNRIsNow commercially available through retail pharmacies and participating Aytu...
Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection
At a median five-year pre-planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA reduced the...
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Net Product Revenue and 2026 Revenue Guidance and Anticipated Development Milestones
Preliminary total global full year 2025 revenue of approximately $616 million Preliminary BRIUMVI U.S. fourth quarter and full year 2025...